Literature DB >> 19688239

Polymerase chain reaction assay for specific identification of Candida guilliermondii (Pichia guilliermondii).

Mariko Yamamura1, Koichi Makimura, Ryuichi Fujisaki, Kazuo Satoh, Sayoko Kawakami, Hajime Nishiya, Yasuo Ota.   

Abstract

The incidence rates of fungemia caused by Candida guilliermondii have been increasing over the past several years. Although still relatively rare (1.3% of all cases of fungemia in Japan), most cases of C. guilliermondii fungemia occur in patients with cancer or hematological malignancy and their mortality rate is high. As C. guilliermondii tends to be resistant to various antifungal agents, early identification of this pathogen and treatment with an appropriate antifungal agent are required to improve survival rates in these patients. However, it is extremely difficult to differentiate C. guilliermondii (Pichia guilliermondii) from members of the C. famata complex. To date, identification based on DNA sequencing has been the only reliable method for the identification of fungal groups. Here, we used a polymerase chain reaction (PCR)-based method that we developed for the simple and reliable identification of C. guilliermondii (P. guilliermondii). A pair of specific primers was designed corresponding to the 18S rDNA sequence. The PCR system was applied to isolates from fungemia patients. These yeasts could not be identified with CHROMagar Candida, but were successfully identified using this PCR-based system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688239     DOI: 10.1007/s10156-009-0701-0

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  5 in total

1.  Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species.

Authors:  Rasmus H Jensen; Maiken C Arendrup
Journal:  J Clin Microbiol       Date:  2010-12-08       Impact factor: 5.948

2.  Candida guilliermondii: biotechnological applications, perspectives for biological control, emerging clinical importance and recent advances in genetics.

Authors:  Nicolas Papon; Vincenzo Savini; Arnaud Lanoue; Andrew J Simkin; Joël Crèche; Nathalie Giglioli-Guivarc'h; Marc Clastre; Vincent Courdavault; Andriy A Sibirny
Journal:  Curr Genet       Date:  2013-04-25       Impact factor: 3.886

3.  Development of Candida-Specific Real-Time PCR Assays for the Detection and Identification of Eight Medically Important Candida Species.

Authors:  Jing Zhang; Guo-Chiuan Hung; Kenjiro Nagamine; Bingjie Li; Shien Tsai; Shyh-Ching Lo
Journal:  Microbiol Insights       Date:  2016-04-18

4.  Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil: study in the period 2007-2010.

Authors:  Vanessa Kummer Perinazzo Oliveira; Luciana da Silva Ruiz; Nélio Alessandro Jesus Oliveira; Débora Moreira; Rosane Christine Hahn; Analy Salles de Azevedo Melo; Angela Satie Nishikaku; Claudete Rodrigues Paula
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jul-Aug       Impact factor: 1.846

5.  Assessment of the Factors Contributing to the Growth or Spoilage of Meyerozyma guilliermondii in Organic Yogurt: Comparison of Methods for Strain Differentiation.

Authors:  Petra Wrent; Eva-María Rivas; Elena Gil de Prado; José M Peinado; María-Isabel de Silóniz
Journal:  Microorganisms       Date:  2015-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.